In Brief
This article was originally published in The Rose Sheet
Executive Summary
Expected guidance on lead in cosmetics is still under development, CFSAN says; Avon finalizes settlement with SEC over China bribery charges. More news in brief.
You may also be interested in...
In Brief: N.J. Bans Microbeads; Prestige Device Sales; Direct Sellers Merge
New Jersey becomes the second state that will prohibit the production and sale of microbeads, as Gov. Chris Christie signs into law a bill that closely follow’s Illinois’ industry-backed legislation. More news in brief.
Analysts On Avon Buyout Rumor: Easier Turnaround ‘Outside The Public Eye’?
Morningstar analyst Eric Lash speculates that the “drastic actions necessary to right Avon’s ship” may be more easily implemented if private equity firm TPG Capital added the direct seller to its portfolio, which already includes Avon Japan. The investment community weighs in on an unconfirmed report that Avon is exploring a potential buyout.
Congressional Appropriators Urge FDA Action On Cosmetic Lead Limits
House and Senate committee reports on proposed FDA appropriations for fiscal 2015 direct the agency to respond to a nearly three-year-old petition requesting an agency-sanctioned limit on trace lead in lipstick and other cosmetics. Appropriators set a March 15, 2015 deadline for FDA’s response.